Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis
Authors:
Open Access
- 1 December 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 160 (12) , 1304-1313
Abstract
Atopic dermatitis (AD) is a common chronic inflammatory skin disease, characterized by eczematous morphology and intense pruritus.1,2 The age of onset of AD is variable and can occur at any point in life, with the highest incidence of onset in childhood.2,3 Prevalence of AD is estimated at 20% in children, with 10% to 20% of cases persisting into adolescence, during which prevalence rates range from 5% to 20%, varying based on geographic location.3-5 Adolescents with AD experience impacts to quality of life that are shared with other age groups, like increased reports of depression and anxiety. Given the importance of psychosocial development during adolescence, AD also impacts identity, relationship building, self-esteem, and school performance.2,6-8 Further, development of autonomy and independence during adolescence can impact adherence and risk-taking behaviors that can challenge treatment plans. Additionally, there are reports of increased suicidal behavior in adolescents with AD.9 Given its negative impacts to adolescent quality of life, there remains a need for treatments available to this population.Keywords
This publication has 22 references indexed in Scilit:
- Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studiesJournal of Allergy and Clinical Immunology, 2022
- Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic DermatitisJAMA Dermatology, 2022
- Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study resultsJournal of Allergy and Clinical Immunology, 2022
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic DermatitisJAMA Dermatology, 2021
- Atopic dermatitisThe Lancet, 2020
- Eczema Herpeticum: Clinical and Pathophysiological AspectsClinical Reviews in Allergy & Immunology, 2019
- The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema AssociationJournal of Investigative Dermatology, 2017
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014